Undecenoic acid with zinc undecenoate
Brand names: Mycota
Undecenoic acid combined with zinc undecenoate is a topical antifungal preparation used to treat superficial dermatophyte infections such as athlete's foot (tinea pedis).
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Undecenoic acid is a fatty acid with fungistatic activity against dermatophytes, while the zinc undecenoate component provides additional antifungal action and a mild astringent effect.
Prescribing in practice
- It is for external use only and should be kept away from the eyes and mucous membranes.
- Local skin irritation or sensitisation can occur; discontinue if irritation develops.
- Treatment should continue for the full recommended course and for a period after symptoms resolve to reduce recurrence, as set out in current prescribing references.
Monitoring
Review the affected skin for resolution of infection and consider an alternative diagnosis or agent if there is no improvement.
Counselling the patient
- Wash and dry the affected area thoroughly, especially between the toes, before applying.
- Keep using it for the full course even after the skin looks better.
- Keep feet dry and change socks regularly to help clearance and prevent recurrence.
Evidence & guidelines
Undecenoate-based preparations are long-established topical antifungals for superficial dermatophyte infections, supported by general clinical experience.
Reference: NICE CKS; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Tumor Lysis Syndrome Risk (Cairo-Bishop) · Oncological Emergency
- FAST Exam Protocol — Focused Assessment with Sonography in Trauma · Trauma
- Urine Anion Gap · Acid-Base
- Bicarbonate Deficit Calculator · Acid-Base
- Delta Ratio for Mixed Acid-Base Disorders · Acid-Base
- Expected PaCO₂ in Metabolic Acidosis (Winter's Formula) · Acid-Base
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD